Meet us in Vienna!

Some members of the lab will present their work at two conferences in April in Vienna.

  10th April 2025, Van Swieten Hall, Medical University of Vienna

Oral presentation:

10th April 11.50‐12.05 Assessing the Therapeutic Potential of an Apramycin‐Gallium Combination for Treating Acinetobacter baumannii Lung  Infections; Anissa Benkhaled et al., Université de Poitiers, Poitiers, France

10th April 14.05‐14.20 Dual AmpC and AmpD mutations in Pseudomonas aeruginosa: Unraveling the Mechanisms of Resistance to Ceftazidime and Avibactam; Albane Rozenholc et al., Université de Poitiers, Poitiers, France

11th April 09:30 – Educational Session: Looking into the crystal ball: exploring the fabulous world of PK-PD simulations – Vincent Aranzana-Climent

 

11- 15 April 2025, Conference center of Vienna

Poster presentation:

 12th April – P2957 – Manogepix and amphotericin B combination is synergistic against Candida glabrata as evidenced by a new pharmacodynamic-modelling approach – Adrien Baillod

 

13th April – P2400 – Assessing the therapeutic potential of an apramycin-gallium combination for treating Acinetobacter baumannii lung infections – Anissa Benkhaled

 

13th April – P0717   – Assessment of in vitro efficacy of three-antitbiotics combinations against Mycob acterium abscessus – Julie Charles

 

13th April – P2320 – Enhancing colistin efficacy against multidrug-resistant Klebsiella pneumoniae using farnesol-loaded lipid nanoparticles – Farras Daffa Imtiyaz

 

14th April – P1604 – Dual AmpC and AmpD mutations in Pseudomonas aeruginosa: unraveling the mechanisms of resistance to ceftazidime and avibactam – Albane Rozenholc

 

 

Mon projet interrégional en 5 minutes

Pr Claire Dahyot-Fizelier, Professor of Anesthesiology and Critical Care Medicine, presents her PHRCI project in 5 minutes!

Call for PHRCI projects in brief:
– SOHO allocation: €4.3m funded by the DGOS (excluding the MERRI D26 envelope) – project ceiling €300,000
– Supports partnership research between health establishments in the same inter-region
– Enables the emergence of projects led by teams wishing to learn about clinical research
– Open to all diseases except HIV-, HBV- and HCV-related infections
– Projects aimed at measuring the effectiveness of health technologies, or assessing the safety, tolerance or feasibility of using health technologies in humans.

For more information on these calls for projects: http://www.girci-soho.fr/appels-projets